Viewing Study NCT00037102


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-02-25 @ 7:50 PM
Study NCT ID: NCT00037102
Status: COMPLETED
Last Update Posted: 2018-04-12
First Post: 2002-05-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
Sponsor: MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module